Document is current
Any future updates will be listed below
-
Authors
Lazzaro, Carlo https://orcid.org/0000-0003-4795-1834
- License Information
-
More Information
Article History
Received: 25 May 2022
Accepted: 6 July 2022
First Online: 21 July 2022
Declarations
:
: Carlo Lazzaro has no conflicts of interest/competing interests with this Letter to the Editor. Outside this Letter to the Editor, in the past three years Carlo Lazzaro has received research grants, speaker or consultancy fees from AstraZeneca S.p.A,, Boehringer Ingelheim Italia S.p.A., CSL Behring S. p.A., Ferring S.p.A., Ipsen S.p.A., Roche S.p.A., Sanofi s.r.l., Santen GmbH, Shire S.p.A, Sobi S.p.A.
